Edmond De Rothschild Holding S.A. Iterum Therapeutics PLC Transaction History

Edmond De Rothschild Holding S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 09, 2022	SELL	$0.21 - $2.9 $19,600 - $270,668	-93,334 Reduced 93.33%	6,666 $11,000
Q1 2021 May 17, 2021	BUY	$0.97 - $2.73 $97,000 - $273,000	100,000 New	100,000 $141,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $21.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.